Trial
NCT04550338
Antiviral Effects of TXA as a Preventative Treatment Following COVID-19 Exposure
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
—
Condition
COVID-19
Intervention
Tranexamic acid
Why stopped
With vaccination efforts ongoing, a feasibility survey indicated there would be inadequate recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-23